Kopran Stock/Share Prices, Buy and Sell Kopran BSE Stocks

Kopran Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

17 Dec 2018 | 11:31 AM

39.10

0.25 (0.64%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-38.81%

Return (1Y)

Underperformed S&P BSE Sensex by 46.98%
More Volatile

2.92%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.13%
Inconsistent Performer

3/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Kopran standalone net profit rises 403.64% in the September 2018 quarter
39 days ago

Kopran standalone net profit rises 403.64% in the September 2018 quarter

08 - Nov - 2018 12:00 AM | 39 days ago

Net profit of Kopran rose 403.64% to Rs 2.77 crore in the quarter ended September 2018 as against Rs 0.55 crore during the previous quarter ended September 2017. Sales rose 59.18% to Rs 49.01 crore in the quarter ended September 2018 as against Rs 30.79 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 49.01 30.79 59
OPM % 10.71 4.58 -
PBDT 4.41 1.35 227
PBT 3.63 0.55 560
NP 2.77 0.55 404
Powered by Capital Market - Live News
Kopran consolidated net profit declines 4.87% in the September 2018 quarter
39 days ago

Kopran consolidated net profit declines 4.87% in the September 2018 quarter

08 - Nov - 2018 12:00 AM | 39 days ago

Net profit of Kopran declined 4.87% to Rs 4.30 crore in the quarter ended September 2018 as against Rs 4.52 crore during the previous quarter ended September 2017. Sales rose 26.54% to Rs 92.15 crore in the quarter ended September 2018 as against Rs 72.82 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 92.15 72.82 27
OPM % 10.93 9.50 -
PBDT 7.56 6.66 14
PBT 5.37 4.52 19
NP 4.30 4.52 -5
Powered by Capital Market - Live News
Kopran to declare Quarterly Result
55 days ago

Kopran to declare Quarterly Result

23 - Oct - 2018 12:00 AM | 55 days ago

Kopran will hold a meeting of the Board of Directors of the Company on 5 November 2018.
Powered by Capital Market - Live News
Kopran reports standalone net loss of Rs 0.70 crore in the June 2018 quarter
129 days ago

Kopran reports standalone net loss of Rs 0.70 crore in the June 2018 quarter

09 - Aug - 2018 12:00 AM | 129 days ago

Net loss of Kopran reported to Rs 0.70 crore in the quarter ended June 2018 as against net profit of Rs 0.30 crore during the previous quarter ended June 2017. Sales rose 16.60% to Rs 27.68 crore in the quarter ended June 2018 as against Rs 23.74 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 27.68 23.74 17
OPM % -0.87 3.75 -
PBDT -0.20 1.13 PL
PBT -0.98 0.30 PL
NP -0.70 0.30 PL
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Kopran Ltd has decreased by -100% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	49.01	30.79	59
OPM %	10.71	4.58	-
PBDT	4.41	1.35	227
PBT	3.63	0.55	560
NP	2.77	0.55	404

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	92.15	72.82	27
OPM %	10.93	9.50	-
PBDT	7.56	6.66	14
PBT	5.37	4.52	19
NP	4.30	4.52	-5

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	27.68	23.74	17
OPM %	-0.87	3.75	-
PBDT	-0.20	1.13	PL
PBT	-0.98	0.30	PL
NP	-0.70	0.30	PL

General Notifications

My Notifications

Research Notifications

Kopran Ltd NSE / BSE Pharmaceuticals, Small Cap

39.10 0.25 (0.64%)

News & Announcements

Price vs Volume

Stock Trivia

Kopran Ltd NSE / BSE
Pharmaceuticals, Small Cap

39.10

0.25 (0.64%)